Enovis Corporation (ENOV)
NYSE: ENOV · Real-Time Price · USD
31.44
+0.38 (1.21%)
Oct 15, 2025, 11:00 AM EDT - Market open
Enovis Revenue
Enovis had revenue of $564.55M in the quarter ending July 4, 2025, with 7.50% growth. This brings the company's revenue in the last twelve months to $2.19B, up 14.40% year-over-year. In the year 2024, Enovis had annual revenue of $2.11B with 23.46% growth.
Revenue (ttm)
$2.19B
Revenue Growth
+14.40%
P/S Ratio
0.80
Revenue / Employee
$297,214
Employees
7,367
Market Cap
1.80B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.11B | 400.43M | 23.46% |
Dec 31, 2023 | 1.71B | 144.10M | 9.22% |
Dec 31, 2022 | 1.56B | 136.91M | 9.60% |
Dec 31, 2021 | 1.43B | 305.49M | 27.26% |
Dec 31, 2020 | 1.12B | -2.21B | -66.32% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
ENOV News
- 7 days ago - Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million - GlobeNewsWire
- 5 weeks ago - Enovis Corporation Announces Time Change for Presentation at Baird 2025 Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Enovis: Healthy Recon Trends Vs. Market Apathy - Seeking Alpha
- 2 months ago - Enovis to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Enovis Corporation (ENOV) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Enovis Announces Second Quarter 2025 Results - GlobeNewsWire
- 3 months ago - Enovis to Host Second Quarter 2025 Results Conference Call on August 7th - GlobeNewsWire
- 5 months ago - Orthopedic Braces & Supports Market Focused Insights 2025-2030, with Key Vendor Profiles for BREG, Bauerfeind, DeRoyals, Enovis, Ottobock, Ossur and Tynor - GlobeNewsWire